These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Cell components of Bordetella pertussis and their biological activities]. Sato Y; Arai H Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077 [No Abstract] [Full Text] [Related]
27. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures. Hollinger E; Wardlaw AC Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814 [No Abstract] [Full Text] [Related]
29. Disturbance of mice tracheal beta-adrenoceptor and cholinergic receptor function by Bordetella pertussis and its cell wall components. Veenendaal GH; Kool DJ; de Wildt DJ; Nijkamp FP Agents Actions; 1986 Dec; 19(5-6):366-7. PubMed ID: 2881459 [No Abstract] [Full Text] [Related]
30. Evaluation of a ribosomal vaccine against pertussis. Field LH; Parker CD; Manclark CR; Berry LJ Infect Immun; 1979 May; 24(2):346-51. PubMed ID: 222684 [TBL] [Abstract][Full Text] [Related]
32. The effect of ifferent bactericidal systems on B. prtussis and B. parapertussis organisms. Pusztai Z; Csizér Z; Joó I Z Immunitatsforsch Allerg Klin Immunol; 1970; 141(1):1-13. PubMed ID: 4322354 [No Abstract] [Full Text] [Related]
33. [Mitogenic action of the liquid phase of a microbial suspension of Bordetella pertussis]. Amelina IP; Pronin AV; Lapaeva IA Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):6-10. PubMed ID: 2890249 [TBL] [Abstract][Full Text] [Related]
34. The amino acid utilization by phase 1 Bordetella pertussis in a chemically defined medium. Goldner M; Jakus CM; Rhodes HK; Wilson RJ J Gen Microbiol; 1966 Sep; 44(3):439-44. PubMed ID: 4291280 [No Abstract] [Full Text] [Related]
35. Studies on the protection test of pertussis vaccine. Immunization period and protectivity. 3. Influence of heat and formation on the vaccine preparation. Yoshioka M; Takatsu K; Kawahira M; Takahashi K Jpn J Microbiol; 1967 Dec; 11(4):311-21. PubMed ID: 4297909 [No Abstract] [Full Text] [Related]
36. Purified K-agglutinogen of Bordetella pertussis and its properties. Nakase Y; Kasuga T Jpn J Microbiol; 1971 May; 15(3):247-56. PubMed ID: 4330023 [No Abstract] [Full Text] [Related]
37. Large-scale production of pertussis vaccine by serial subculture technic. Csizér Z; Joó I Zentralbl Bakteriol Orig A; 1972 Jul; 221(1):59-64. PubMed ID: 4145107 [No Abstract] [Full Text] [Related]
38. [Effect of the passive immunization on the sensitizing activity of Bordetella pertussis. I. Increase of sensitivity to repeated homologous antigen administrations]. Sumarokov AA; Kulikova IuM Zh Mikrobiol Epidemiol Immunobiol; 1965 May; 42(5):33-8. PubMed ID: 4161435 [No Abstract] [Full Text] [Related]
39. Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm. MUNOZ J; RIBI E; LARSON CL J Immunol; 1959 Nov; 83():496-501. PubMed ID: 14425265 [No Abstract] [Full Text] [Related]
40. Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs. Azuma I; Sugimura K; Yamamura Y; Kusumoto S; Tarumi Y Jpn J Microbiol; 1976 Feb; 20(1):63-6. PubMed ID: 1271589 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]